Parkinsonism Clinical Trial
Official title:
Measurement of Gait Using the Opal APDM and an Instrumented Gait Mat in Persons With Parkinsonism
The project is a prospective trial comparing Zeno/GAITRite and APDM® in a cohort of persons
living with parkinsonian disorders. Ambulatory patients with a parkinsonian syndrome and who
are able to provide informed consent will participate in the assessments.
Outcome variables include selected gait and balance parameters such as cadence, gait-cycle,
stride-length, stride-velocity, turning duration, turning steps, postural sway and
anticipatory postural control. These parameters will be measured by the portable inertial
sensors developed by APDM® and the Zeno/GaitRite.
Testing
Participants after screening and consenting will:
1. Have their height measured and fit with the APDM Opals (each device is a two inch square
attached by velcro), one device is attached to each leg, each arm, and the trunk and
chest and receive an introduction to walking on the gait mat.
2. Participants are then asked to walk at a self selected walking speed down the gait mat.
The participants will complete multiple passes (8-10 passes, total 75-100 feet) across
the gait mat while wearing the APDM units to concurrently collect all temporal and
spatial data needed to answer the research question. The Zeno mat is the intended
primary gait mat for this study. The GaitRite will only be utilized in the case of a
technical issue with the Zeno in order to insure completion of the data collection.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02194816 -
Modifiable Variables in Parkinsonism (MVP)
|
||
| Recruiting |
NCT04876326 -
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy
|
N/A | |
| Active, not recruiting |
NCT05127057 -
Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)
|
N/A | |
| Enrolling by invitation |
NCT01453127 -
DaTSCAN Imaging in Aging and Neurodegenerative Disease
|
Phase 4 | |
| Completed |
NCT01174771 -
Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
|
N/A | |
| Completed |
NCT03314610 -
Effect of Need to Void on Parkinsonian Gait
|
||
| Recruiting |
NCT05506891 -
Efficacy and Safety of Astragalus for Non-motor Symptoms of α-Synucleinopathy
|
Phase 2 | |
| Completed |
NCT00950196 -
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
|
Phase 4 | |
| Recruiting |
NCT03924414 -
Trial of Parkinson's And Zoledronic Acid
|
Phase 4 | |
| Enrolling by invitation |
NCT05514106 -
MIBG in Aging and Neurologic Disorders
|
Phase 4 | |
| Completed |
NCT01581645 -
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
|
Phase 0 | |
| Not yet recruiting |
NCT00767546 -
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
|
Phase 1 | |
| Completed |
NCT02214862 -
2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism
|
Phase 0 | |
| Recruiting |
NCT04518059 -
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
|
||
| Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A | |
| Withdrawn |
NCT01329926 -
Molecular Analysis of Human Neural Stem Cells
|
||
| Terminated |
NCT00745030 -
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
|
N/A | |
| Completed |
NCT04222218 -
Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy
|
N/A | |
| Completed |
NCT03386669 -
Novel Neuroimage Study in Tauopathies With Parkinsonism
|
Phase 2 | |
| Active, not recruiting |
NCT05308485 -
Events Exposure as a Trigger of the Clinical Manifestations of Parkinson's Disease
|